Clinical Trials · NCT00008073
Octreotide and Doxorubicin in Treating Patients With Advanced Cancer
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- University of Pittsburgh
- Enrollment
- 0
- Start date
- Jan 1996
- Locations
- 1 site, United States
- Primary endpoint
- Study in Unspecified Adult Solid Tumor, Protocol Specific